Have Global Firms Gained From India’s Price Caps?
This article was originally published in PharmAsia News
Executive Summary
After a prolonged period of shrinking market share and dimming prospects, global drug makers are seeing a rebound in India, with some even outclassing their local rivals in highly prescribed categories. If the trend continues, drug makers may be encouraged to pump in further investments, say experts.